Immunopathogenesis of equine infectious anemia lentivirus disease.
Abstract: Virus replication and subsequent viremia are clearly correlated with clinical disease in EIAV infected horses. Termination of viremia is the result of specific immune responses. Recurrences of viremia are associated with antigenic variation of neutralization-sensitive epitopes. Immunosuppression experiments indicate that the eventual control of EIAV and development of carriers is mediated by the immune system. Even though the immune response to EIAV has a protective effect, immune responses also cause some of the lesions. At least one part of the anemia, erythrocyte destruction, is caused by the immune response. Not all of the mechanisms of decreased erythropoiesis are known, but EIAV infection of monocyte/macrophages results in altered iron metabolism and functional iron deficiency. Viral antigen-antibody-C3 complexes cause glomerulitis and the combination of antigen-antibody reactions results in significant reductions in plasma C3. Lesions in the liver and other organs are infiltrations of lymphocytes and monocytes/macrophages in the interstitial areas and it is assumed that these lesions are initiated by specific immune responses to viral antigens. The observations on kinetics of EIAV infection, immune control by the horse, and immunopathologic basis of most of the lesions lead to the conclusion that mechanisms of lentivirus control and disease can be determined by study of EIAV.
Publication Date: 1990-01-01 PubMed ID: 2178127
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
- Research Support
- Non-U.S. Gov't
- Research Support
- U.S. Gov't
- Non-P.H.S.
- Research Support
- U.S. Gov't
- P.H.S.
- Review
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The research article discusses the relationship between the immune response and the manifestation of EIAV (equine infectious anemia lentivirus) disease in horses, indicating how the immune response both controls the virus and contributes to some of its effects.
Overview of the Study
- The study examines the interplay between the Equine Infectious Anemia Lentivirus (EIAV) disease and the immune response in horses.
- It looks into how viral replication and viremia (presence of virus in the blood) correlate with the manifestation of EIAV disease, the role of specific immune responses in terminating viremia, and how recurrences of viremia are associated with antigenic variation of neutralization-sensitive epitopes (parts of an antigen recognized by the immune system).
Role of Immune System
- The research notes that control of EIAV and the development of carriers are facilitated by the immune system. This is affirmed by immunosuppression experiments conducted during the study.
- However, the immune response to EIAV seems to have a dual role, as it can also lead to some of the disease-related lesions in horses.
Effects on Erythropoiesis and Iron Metabolism
- One aspect of the anemia involved in EIAV, erythrocyte destruction, is found to be caused by the immune response.
- While not all processes affecting erythropoiesis (the production of red blood cells) are fully understood, the study identifies EIAV infection of monocyte/macrophages as an agent responsible for altered iron metabolism and functional iron deficiency.
Implications on Physical Lesions
- The researchers identify viral antigen-antibody-C3 complexes as the cause of glomerulitis, an inflammatory condition of the kidneys, and note that antigen-antibody reactions cause significant reductions in plasma C3, a protein involved in the immune system’s complement system.
- They also note that lesions in the liver and other organs are characterized by infiltrations of lymphocytes and monocytes/macrophages into the interstitial areas. The researchers posit that these lesions are initiated by specific immune responses to viral antigens.
Conclusion and Future Research Directions
- From the observations on the kinetics of EIAV infection, immune control by the horse and the immunopathologic basis of most of the lesions, the researchers conclude that understanding the controlling mechanisms of lentivirus and related diseases can be achieved through further study of EIAV. This could provide more insights into the pathology and control of similar diseases, offering potential for better management and treatments.
Cite This Article
APA
McGuire TC, O'Rourke KI, Perryman LE.
(1990).
Immunopathogenesis of equine infectious anemia lentivirus disease.
Dev Biol Stand, 72, 31-37.
Publication
Researcher Affiliations
- Department of Veterinary Microbiology and Pathology, College of Veterinary Medicine, Washington State University, Pullman 99164-7040.
MeSH Terms
- Animals
- Antigen-Antibody Complex / immunology
- Antigens, Viral / analysis
- DNA, Viral / analysis
- Equine Infectious Anemia / immunology
- Equine Infectious Anemia / microbiology
- Erythrocytes / immunology
- Horses
- Infectious Anemia Virus, Equine / immunology
- Infectious Anemia Virus, Equine / physiology
- Virus Replication
Grant Funding
- AI 24166 / NIAID NIH HHS
- AI 24291 / NIAID NIH HHS
Citations
This article has been cited 9 times.- Liu L, Wan Y, Wu L, Sun J, Li H, Li H, Ma L, Shao Y. Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine. Retrovirology 2010 Sep 1;7:71.
- Taylor SD, Leib SR, Carpenter S, Mealey RH. Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses. J Virol 2010 Jul;84(13):6536-48.
- Covaleda L, Fuller FJ, Payne SL. EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages. Virology 2010 Feb 5;397(1):217-23.
- Mealey RH, Leib SR, Littke MH, Wagner B, Horohov DW, McGuire TC. Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen. Vaccine 2009 Apr 21;27(18):2453-68.
- Mealey RH, Lee JH, Leib SR, Littke MH, McGuire TC. A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL. J Immunol 2006 Nov 15;177(10):7377-90.
- Mealey RH, Sharif A, Ellis SA, Littke MH, Leib SR, McGuire TC. Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes. Virology 2005 Aug 15;339(1):110-26.
- Mealey RH, Zhang B, Leib SR, Littke MH, McGuire TC. Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus. Virology 2003 Sep 1;313(2):537-52.
- Mealey RH, Fraser DG, Oaks JL, Cantor GH, McGuire TC. Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses. Clin Immunol 2001 Nov;101(2):237-47.
- Lonning SM, Zhang W, Leib SR, McGuire TC. Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors. J Virol 1999 Apr;73(4):2762-9.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists